Tarik El Amrani

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2009

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
March 2009 - September 2014
Osteosarcoma
Placebo
Saracatinib



